News
Important Only
Genasys Inc. Q2 Adjusted EBITDA USD -5.149 Million
May 13 (Reuters) - Genasys Inc GNSS.O:GENASYS INC. Q2 ADJUSTED EBITDA USD -5.149 MILLIONGENASYS INC. Q2 NET INCOME USD -6.139 MILLIONGENASYS INC. Q2 GROSS PROFIT USD 2.61 MILLIONGENASYS INC. Q2 INCOME FROM OPERATIONS USD -6.255 MILLIONGENASYS INC. Q2 PRETAX PROFIT USD -6.068 MILLIONGENASYS INC. Q2 R...Reuters
Tue, May 13
TransAct Technologies Q1 Operating Income USD -15 Thousand
May 13 (Reuters) - TransAct Technologies Inc TACT.O:TRANSACT TECHNOLOGIES Q1 OPERATING INCOME USD -15 THOUSANDTRANSACT TECHNOLOGIES Q1 GROSS MARGIN 48.7%TRANSACT TECHNOLOGIES Q1 EPS USD 0TRANSACT TECHNOLOGIES Q1 NET INCOME USD 19 THOUSANDTRANSACT TECHNOLOGIES Q1 ADJUSTED EBITDA USD 544 THOUSANDTRANS...Reuters
Tue, May 13
Prairie Operating Co expected to post earnings of 84 cents a share - Earnings Preview
Prairie Operating Co PROP.OQ PROP.O is expected to show a rise in quarterly revenue when it reports results on May 15 (estimated) for the period ending March 31 2025The Houston Texas-based company is expected to report revenue of $95.39 million, according to the mean estimate from 2 analysts, base...Reuters
Tue, May 13
Applied DNA Sciences Inc expected to post a loss of $3.00 a share - Earnings Preview
Applied DNA Sciences Inc APDN.OQ APDN.O is expected to show a rise in quarterly revenue when it reports results on May 15 (estimated) for the period ending March 31 2025The Stony Brook New York-based company is expected to report a 27.5% increase in revenue to $1.185 million from $929.63 thousand ...Reuters
Tue, May 13
Grail Reports First Quarter 2025 Financial Results
May 13 (Reuters) - Grail Inc GRAL.O:GRAIL REPORTS FIRST QUARTER 2025 FINANCIAL RESULTSGRAIL INC: POSITIVE TOP-LINE RESULTS FROM PREVALENT SCREENING ROUND OF NHS-GALLERI TRIALGRAIL INC: CASH POSITION OF $677.9 MILLION PROVIDES RUNWAY INTO 2028GRAIL INC -QTRLY REVENUE $31.8 MILLIONGRAIL INC: PLAN TO S...Reuters
Tue, May 13
AN2 Therapeutics Q1 Operating Expenses USD 11.537 Million
May 13 (Reuters) - AN2 Therapeutics Inc ANTX.O:AN2 THERAPEUTICS Q1 OPERATING EXPENSES USD 11.537 MILLIONAN2 THERAPEUTICS Q1 INCOME FROM OPERATIONS USD -11.537 MILLIONAN2 THERAPEUTICS Q1 NET INCOME USD -10.649 MILLIONAN2 THERAPEUTICS Q1 EPS USD -0.35Reuters
Tue, May 13
Biodesix Q1 Operating Expenses USD 900 Thousand
May 13 (Reuters) - Biodesix Inc BDSX.O:BIODESIX Q1 OPERATING EXPENSES USD 900 THOUSANDBIODESIX Q1 NET INCOME USD -11.1 MILLIONBIODESIX Q1 ADJUSTED OPERATING EXPENSES USD 23.4 MILLIONBIODESIX Q1 REVENUE USD 18 MILLION VERSUS. IBES ESTIMATE USD 19.5 MILLIONUPDATES 2025 REVENUE GUIDANCE TO $80-85 MILLI...Reuters
Tue, May 13
InterRent Real Estate Investment Trust expected to post a share - Earnings Preview
InterRent Real Estate Investment Trust IIP_u.TO is expected to show a rise in quarterly revenue when it reports results on May 15 for the period ending March 31 2025The Ottawa Ontario-based company is expected to report a 1.1% increase in revenue to C$62.8 million from C$62.1 million a year ago, ...Reuters
Tue, May 13
Sensus Healthcare Inc expected to post earnings of 3 cents a share - Earnings Preview
Sensus Healthcare Inc SRTS.OQ SRTS.O is expected to show a fall in quarterly revenue when it reports results on May 15 for the period ending March 31 2025The Boca Raton Florida-based company is expected to report a 32.2% decrease in revenue to $7.234 million from $10.66 million a year ago, accordi...Reuters
Tue, May 13
